Tenon Medical (TNONW) EBIT (2021 - 2026)

Tenon Medical's EBIT history runs 6 years deep, the most recent figure standing at -$3.3 million for Q1 2026.

• In Q1 2026, EBIT rose 10.8% year-over-year to -$3.3 million; the TTM figure through Mar 2026 stood at -$12.4 million (up 11.06% YoY), while the FY2025 annual figure was -$12.8 million, up 7.08% from the prior year.
• EBIT was -$3.3 million for Q1 2026 at Tenon Medical, down from -$2.9 million in the prior quarter.
• In the past five years, EBIT ranged from a high of -$2.1 million in Q1 2022 to a low of -$7.9 million in Q4 2022.
• Historically, EBIT has averaged -$3.8 million across 5 years, with a median of -$3.4 million in 2023.
• The sharpest annual moves came in 2022 and 2023: EBIT tumbled 1000.0% in 2022, then jumped 60.38% in 2023.
• A 5-year view of EBIT shows it stood at -$7.9 million in 2022, then surged by 60.38% to -$3.1 million in 2023, then retreated by 1.02% to -$3.2 million in 2024, then gained by 9.68% to -$2.9 million in 2025, then declined by 14.45% to -$3.3 million in 2026.
• The last three EBIT figures came in at -$3.3 million (Q1 2026), -$2.9 million (Q4 2025), and -$3.4 million (Q3 2025), per Business Quant data.